Re: Cycloserine Enantiomers are Reversible Inhibitors of Human Alanine:Glyoxylate Aminotransferase: Implications for Primary Hyperoxaluria Type 1.
Publication
, Journal Article
Assimos, DG
Published in: J Urol
May 2020
Duke Scholars
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
May 2020
Volume
203
Issue
5
Start / End Page
876 / 877
Location
United States
Related Subject Headings
- Urology & Nephrology
- Transaminases
- Hyperoxaluria, Primary
- Humans
- Cycloserine
- Alanine
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Assimos, D. G. (2020). Re: Cycloserine Enantiomers are Reversible Inhibitors of Human Alanine:Glyoxylate Aminotransferase: Implications for Primary Hyperoxaluria Type 1. J Urol, 203(5), 876–877. https://doi.org/10.1097/JU.0000000000000776.03
Assimos, Dean G. “Re: Cycloserine Enantiomers are Reversible Inhibitors of Human Alanine:Glyoxylate Aminotransferase: Implications for Primary Hyperoxaluria Type 1.” J Urol 203, no. 5 (May 2020): 876–77. https://doi.org/10.1097/JU.0000000000000776.03.
Assimos DG. Re: Cycloserine Enantiomers are Reversible Inhibitors of Human Alanine:Glyoxylate Aminotransferase: Implications for Primary Hyperoxaluria Type 1. J Urol. 2020 May;203(5):876–7.
Assimos, Dean G. “Re: Cycloserine Enantiomers are Reversible Inhibitors of Human Alanine:Glyoxylate Aminotransferase: Implications for Primary Hyperoxaluria Type 1.” J Urol, vol. 203, no. 5, May 2020, pp. 876–77. Pubmed, doi:10.1097/JU.0000000000000776.03.
Assimos DG. Re: Cycloserine Enantiomers are Reversible Inhibitors of Human Alanine:Glyoxylate Aminotransferase: Implications for Primary Hyperoxaluria Type 1. J Urol. 2020 May;203(5):876–877.
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
May 2020
Volume
203
Issue
5
Start / End Page
876 / 877
Location
United States
Related Subject Headings
- Urology & Nephrology
- Transaminases
- Hyperoxaluria, Primary
- Humans
- Cycloserine
- Alanine
- 3202 Clinical sciences
- 1103 Clinical Sciences